Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1590/0001-3765202020200466 http://scihub22266oqcxt.onion/10.1590/0001-3765202020200466 32556054!ä!32556054 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       An+Acad+Bras+Cienc 2020 ; 92 (2): e20200466 Nephropedia Template TP {{tp|p=32556054|t=2020. COVID-19: therapeutic approaches description and discussion |pdf=|usr=}}{{32556054}} gab.com Text COVID-19: therapeutic approaches description and discussion JO: An Acad Bras Cienc http://www.kidney.de/pget.php?&tw=1&pmid=32556054 #FOAvip COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the "Spanish flu" pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date. Twit Text FOAVip COVID-19: therapeutic approaches description and discussion ????An Acad Bras Cienc http://www.kidney.de/pget.php?&tw=1&pmid=32556054 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32556054 #FOAvip English Wikipedia <ref>{{Cite pmid|32556054}}</ref> COVID-19: therapeutic approaches description and discussion #MMPMID32556054 Trindade GG; Caxito SMC; Xavier AREO; Xavier MAS; BrandAo F An Acad Bras Cienc 2020[]; 92 (2): e20200466 PMID32556054show ga COVID-19 emerged in December 2019 in China, and since then, has disrupted global public health and changed economic paradigms. In dealing with the new Coronavirus, SARS-CoV-2, the world has not faced such extreme global fragility since the "Spanish flu" pandemic in 1918. Researchers globally are dedicating efforts to the search for an effective treatment for COVID-19. Drugs already used in a clinical setting for other pathologies have been tested as a new therapeutic approach against SARS-CoV-2, setting off a frenzy over the preliminary data of different studies. This work aims to compile and discuss the data published thus far. Despite the potential effects of some antivirals and antiparasitic against COVID-19, clinical studies must confirm real effectiveness. However, non-pharmacological approaches have proven to be the most efficient strategy to date. |Anti-Bacterial Agents/*administration & dosage/chemistry/pharmacology[MESH] |Antiparasitic Agents/*administration & dosage/chemistry/pharmacology[MESH] |Antiviral Agents/*administration & dosage/chemistry/pharmacology[MESH] |Betacoronavirus/*drug effects[MESH] |COVID-19[MESH] |Coronavirus Infections/*drug therapy[MESH] |Humans[MESH] |Macrolides/*administration & dosage/chemistry/pharmacology[MESH] |Pandemics[MESH] |Pneumonia, Viral/*drug therapy[MESH] |SARS-CoV-2[MESH]COVID-19: therapeutic approaches description and discussion (epmc).pdf DeepDyve Pubget Overpricing